⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3148508 | 0.75 | — | — | |
| SCHEMBL1922601 | 0.75 | — | — | |
| SCHEMBL3906570 | 0.73 | — | — | |
| SCHEMBL77218 | 0.71 | — | — | |
| SCHEMBL10022977 | 0.71 | NOS1 (0.52) | — | |
| SCHEMBL27982173 | 0.71 | — | — | |
| SCHEMBL22865268 | 0.71 | — | — | |
| SCHEMBL15304320 | 0.71 | — | — | |
| SCHEMBL11489805 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL27810722 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1753683-B | Ophthalmic formulation for the prevention and treatment of ocular conditions | CHAKSHU RES INC | 2010-05-26 | — | — | CN | claimed |
| EP-1751113-B1 | UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS | BRISTOL MYERS SQUIBB CO (US) | 2010-03-10 | — | — | EP | claimed |
| CN-1753683-A | Ophthalmic formulation for the prevention and treatment of ocular conditions | CHAKSHU RES INC (US) | 2006-03-29 | — | — | CN | claimed |
| US-20040019219-A1 | N-alkylated thiazolium salts and process for their preparation | LANXESS DEUTSCHLAND GMBH (DE) | 2004-01-29 | — | — | US | claimed |
| EP-1371651-A2 | N-alkylated Thiazoliumsalts and processes for their preparation | BAYER AG (DE) | 2003-12-17 | — | — | EP | claimed |
| EP-4448492-B1 | COMPOSITIONS AND METHODS OF MAKING AND USING SMALL MOLECULES IN THE TREATMENT OF CANCER | REGLAGENE INC (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-4658656-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | Beone Medicines I GmbH (CH) | 2025-12-10 | — | — | EP | disclosed |
| US-20250346597-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | BEONE MEDICINES I GMBH (CH) | 2025-11-13 | — | — | US | disclosed |
| EP-4630025-A1 | EXTRACT OF ALGAE OF THE GENUS ULVA FOR THE TREATMENT OF DISORDERS CAUSED BY A METABOLIC SYNDROME | UNIVERSITE DE BORDEAUX (FR) | 2025-10-15 | — | — | EP | disclosed |
| US-12404242-B2 | Compositions and methods for making and using small molecules in the treatment of cancer | REGLAGENE, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| EP-4269400-B1 | YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | MOLECURE SA (PL) | 2025-07-09 | — | — | EP | disclosed |
| EP-4543544-A1 | TYROSINE KINASE 2 INHIBITORS AND USES THEREOF | Biogen MA Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20020156287-A1 | Condensation reagents and a process for their preparation | LANXESS DEUTSCHLAND GMBH (DE) | 2002-10-24 | — | — | US | disclosed |
| EP-1216997-A2 | 2-bromo/chloro-thiazolium salts and their use as condensation agents | BAYER AG (DE) | 2002-06-26 | — | — | EP | disclosed |
| EP-1214303-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | Merck & Co., Inc. (US) | 2002-06-19 | — | — | EP | disclosed |
| WO-2001016121-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | MERCK & CO., INC. (US) | 2001-03-08 | — | — | WO | disclosed |
| US-5877156-A | Thrombin inhibitors | AKZO NOBEL, N.V. (NL) | 1999-03-02 | — | — | US | disclosed |
| EP-0884325-A1 | Thrombin inhibitors containing a peptidyl heterocycle | Akzo Nobel N.V. (NL) | 1998-12-16 | — | — | EP | disclosed |
| US-5030727-A | Reacting an anthronilide derivative with a thiazole derivative or a fluorozuinazolone with a neucleophile | BASF AKTIENGESELLSCHAFT (DE) | 1991-07-09 | — | — | US | disclosed |
| EP-0263523-A2 | Process for the preparation of thiazolo [2,3-b] quinazolones | BASF Aktiengesellschaft (DE) | 1988-04-13 | — | — | EP | disclosed |